BIOMAT Database Logo BIOMAT Database Logo

Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium. 2011

Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Department of Cardiac Surgery, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.

OBJECTIVE Inadequate capillary growth in pressure-overload hypertrophy impairs myocardial perfusion and substrate delivery, contributing to progression to failure. Capillary growth is tightly regulated by angiogenesis growth factors like vascular endothelial growth factor (VEGF) and endogenous inhibitors such as the splice variant of VEGF receptor-1, sVEGFR-1. We hypothesized that inadequate expression of VEGF and up-regulation of VEGFR-1 and its soluble splice variant, sVEGFR-1, restrict capillary growth in pressure-overload hypertrophy. RESULTS Neonatal New Zealand White rabbits underwent aortic banding. mRNA (qRT-PCR) and protein levels (immunoblotting) were determined in hypertrophied and control myocardium (7/group) for total VEGF, VEGFR-1, sVEGFR-1, VEGFR-2, and phospho-VEGFR-1 and -R-2. Free VEGF was determined by enzyme-linked immunoassay (ELISA) in hypertrophied myocardium, controls, and hypertrophied hearts following inhibition of sVEGFR-1 with placental growth factor (PlGF). VEGFR-1 and sVEGFR-1 mRNA (seven-fold up-regulation, P = 0.001) and protein levels were significantly up-regulated in hypertrophied hearts vs. controls (VEGFR-1: 44 ± 8 vs. 23 ± 1, P = 0.031; sVEGFR-1: 71 ± 13 vs. 31 ± 3, P = 0.016). There was no change in VEGF and VEGFR-2 mRNA or protein levels in hypertrophied compared with controls hearts. A significant decline in free, unbound VEGF was found in hypertrophied myocardium which was reversed following inhibition of sVEGFR-1 with PlGF, which was accompanied by phosphorylation of VEGFR-1 and VEGFR-2. CONCLUSIONS Up-regulation of the soluble VEGFR-1 in pressure-loaded myocardium prevents capillary growth by trapping VEGF. Inhibition of sVEGFR-1 released sufficient VEGF to induce angiogenesis and preserved contractile function. These data suggest sVEGFR-1 as possible therapeutic targets to prevent heart failure.

UI MeSH Term Description Entries
D008026 Ligation Application of a ligature to tie a vessel or strangulate a part. Ligature,Ligations,Ligatures
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart
D000072483 Placenta Growth Factor An angiogenic protein belonging to the Vascular Endothelial Growth Factor family of growth factors originally isolated and cloned from human placental cDNA library. There are four isoforms of PLGF 1-4 which result from alternative splicing. Placenta Growth Factor is secreted as a glycosylated homodimer which acts as a mitogen for endothelial cells, and its expression is markedly upregulated during hypoxia and in tissue inflammation and cancer. Placenta Growth Factor, PLGF-1 Isoform,Placenta Growth Factor, PLGF-2 Isoform,Placenta Growth Factor, PLGF-3 Isoform,Placenta Growth Factor, PLGF-4 Isoform,Factor, Placenta Growth,Growth Factor, Placenta,Placenta Growth Factor, PLGF 1 Isoform,Placenta Growth Factor, PLGF 2 Isoform,Placenta Growth Factor, PLGF 3 Isoform,Placenta Growth Factor, PLGF 4 Isoform

Related Publications

Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.
April 2018, International journal of molecular sciences,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
October 2007, Circulation research,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis.
January 2005, Endothelium : journal of endothelial cell research,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
October 2004, Circulation research,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
February 2009, Circulation,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularization.
March 2014, The Journal of biological chemistry,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
September 2001, The American journal of pathology,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor.
August 2002, Cancer gene therapy,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1.
June 2000, Blood,
Elisabeth Kaza, and Klemens Ablasser, and Dimitrios Poutias, and Eric R Griffiths, and Fawzy A Saad, and Jochen G Hofstaetter, and Pedro J del Nido, and Ingeborg Friehs
Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis.
August 2007, Critical care medicine,
Copied contents to your clipboard!